|
Duration of Treatment |
Treatment Groups |
Osteoarthritis and/or Rheumatoid
Arthritis |
N49-96-02-012 |
4 Wks |
placebo, celecoxib 40 mg BID,
celecoxib 200 mg BID, celecoxib 400 mg BID |
N49-96-02-020 |
12 Wks |
placebo, celecoxib 50 mg BID,
celecoxib 100 mg BID, celecoxib 200 mg BID, naproxen 500 mg BID |
N49-96-02-021 |
12 Wks |
placebo, celecoxib 50 mg BID,
celecoxib 100 mg BID, celecoxib 200 mg BID, naproxen 500 mg BID |
N49-96-02-022 |
12 Wks |
placebo, celecoxib 100 mg BID,
celecoxib 200 mg BID, celecoxib 400 mg BID, naproxen 500 mg BID |
N49-96-02-023 |
12 Wks |
placebo, celecoxib 100 mg BID,
celecoxib 200 mg BID, celecoxib 400 mg BID, naproxen 500 mg BID |
I49-96-02-041 |
24 Wks |
celecoxib 200 mg BID, diclofenac SR
75 mg BID |
I49-96-02-042 |
6 Wks |
celecoxib 100 mg BID, diclofenac 50
mg BID |
N49-96-02-047 |
4 Wks |
placebo, celecoxib 25 mg BID, celecoxib
100 mg BID, celecoxib
400 mg BID |
N49-96-02-054 |
12 Wks |
placebo, celecoxib 50 mg BID,
celecoxib 100 mg BID, celecoxib 200 mg BID, naproxen 500 mg BID |
N49-96-02-060 |
6 Wks |
placebo, celecoxib 100 mg BID,
celecoxib 200 mg QD |
N49-96-02-062 |
12 Wks |
celecoxib 200 mg, naproxen 500 mg
BID |
N49-96-02-071 |
12 Wks |
celecoxib 200 mg BID, diclofenac 75
mg BID, Ibuprofen 800 mg TID |
N49-96-02-087 |
6 Wks |
placebo, celecoxib 100 mg BID,
celecoxib 200 mg QD |
I49-96-02-096 |
12 Wks |
celecoxib 100 mg BID, celecoxib 200
mg BID, diclofenac 50 mg BID, naproxen 500 mg BID |
N49-96-02-035/102
(CLASS trial) |
Event-driven: median 6-9 months |
celecoxib 400 mg BID, ibuprofen 800
mg TID, diclofenac 75 BID |
I49-96-02-105 |
12 Wks |
celecoxib 100 mg BID, diclofenac 50
mg BID |
I49-96-02-106 |
12 Wks |
celecoxib 100 mg BID, diclofenac 50
mg BID |
I49-96-02-107 |
12 Wks |
celecoxib 100 mg BID, diclofenac 50
mg BID |
N49-96-02-118 |
6 Wks |
placebo, celecoxib 100 mg BID,
diclofenac 50 mg TID |
N49-96-02-149 |
6 Wks |
celecoxib 200 mg QD, rofecoxib 25 mg
QD |
N49-96-02-152 |
6 Wks |
celecoxib 200 mg QD, rofecoxib 25 mg
QD |
N49-96-02-181 |
6 Wks |
celecoxib 200 mg QD, rofecoxib 25 mg
QD |
J49-01-02-216 |
4 Wks |
placebo, celecoxib 100 mg BID,
loxoprofen 60 mg TID |
635-IFL-0508-002 |
12 Wks |
celecoxib 200 mg QD, rofecoxib 25 mg
QD, naproxen 500 mg BID |
635-IFL-0508-003 |
6 Wks |
placebo, celecoxib 200 mg QD,
rofecoxib 25 mg QD |
A3191006 |
52 Wks |
celecoxib 200 mg QD, diclofenac 50
mg BID |
A3191025 |
1 yra
|
celecoxib 200 mg QD, diclofenac 50
mg BID |
A3191051 |
6 Wks |
placebo, celecoxib 200 mg QD,
naproxen 500 mg BID |
A3191052 |
6 Wks |
placebo, celecoxib 200 mg QD,
naproxen 500 mg BID |
A3191053 |
6 Wks |
placebo, celecoxib 200 mg QD,
naproxen 500 mg BID |
A3191062 |
6 Wks |
placebo, celecoxib 200 mg QD,
ibuprofen 800 mg TID |
A3191063 |
6 Wks |
placebo, celecoxib 200 mg QD,
ibuprofen 800 mg TID |
A3191069 |
6 Wks |
placebo, celecoxib 200 mg QD |
A3191082 |
6 Wks |
placebo, celecoxib 200 mg QD |
A3191152 |
6 Mths |
celecoxib 200 mg QD, naproxen 500 mg
BID |
COXA-0508-261 |
12 Wks |
celecoxib 200 mg QD, diclofenac 50
mg TID |
Ankylosing Spondylitis |
F49-98-02-137 |
6 Wks |
placebo, celecoxib 100 mg BID,
ketoprofen 100 mg BID |
N49-01-02-193 |
12 Wks |
placebo, celecoxib 200 mg QD,
celecoxib 400 mg QD, naproxen 500 mg BID |
COXA-0503-243 |
12 Wks |
celecoxib 200 mg QD, celecoxib 200
mg BID, diclofenac 75 mg SR BID |
COXA-0503-247 |
12 Wks |
celecoxib 200 mg QD, celecoxib 400
mg QD, diclofenac 75 mg TID |
Chronic Low Back Pain |
J49-01-02-217 |
4 Wks |
celecoxib 100 mg BID, loxoprofen 60
mg TID |
COXA-0508-244 |
12 Wks |
placebo, celecoxib 200 mg QD |
COXA-0508-245 |
12 Wks |
placebo, celecoxib 200 mg QD |
COXA-0508-269 |
12 Wks |
placebo, celecoxib 200 mg QD,
celecoxib 200 mg BID |
A3191174 |
4 Wks |
celecoxib 200 mg BID, loxoprofen 60
mg TID |
Alzheimer Disease |
IQ5-97-02-001 |
52 Wks |
placebo, celecoxib 200 mg BID |
EQ5-98-02-002 |
3 yra
|
placebo, celecoxib 200 mg BID |
NQ5-98-02-005 |
4 Wks |
placebo, celecoxib 200 mg BID |
Spontaneous Colorectal
Adenomatous Polyps |
NQ4-00-02-011 |
12 Wksa
|
placebo, celecoxib 100 mg BID,
celecoxib 200 mg BID, celecoxib 400 mg BID |
EQ4-00-02-018 |
3 ya
|
placebo, celecoxib 400 mg QD |
IQ4-99-02-005 |
3ya
|
placebo, celecoxib 200 mg BID,
celecoxib 400 mg BID |